11 May 2023
Kirkland Advises Patient Square Capital in Consortium Acquisition of Syneos Health for Approximately $7.1 Billion
Advising firms
Deal team
10 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Maggie Flores Lead | Kirkland & Ellis | Partner | corporate | Not stated |
| Michael Weisser Lead | Kirkland & Ellis | Partner | corporate | Not stated |
| Daniel Wolf Lead | Kirkland & Ellis | Partner | corporate | Not stated |
| Zach Miller | Kirkland & Ellis | Associate | corporate | Not stated |
| Jason Kanner | Kirkland & Ellis | Partner | debt finance | Not stated |
| John Ilardo | Kirkland & Ellis | Partner | debt finance | Not stated |
| Rohit Nafday | Kirkland & Ellis | Partner | executive compensation | Not stated |
| Paige Costakos | Kirkland & Ellis | Associate | executive compensation | Not stated |
| Mark Schwed | Kirkland & Ellis | Partner | tax | Not stated |
| Alee Jamel | Kirkland & Ellis | Associate | tax | Not stated |
Stated terms
- Stated value
- USD 7.10bn (approximately $7.1 billion)
- What the figure measures
- Total transaction value
- Client
- Patient Square CapitalBuy-side
- Counterparties
- Syneos Health, Inc. (Target)
Elliott Investment Management (Buy-side)
Veritas Capital (Buy-side)